Madras HC issues notice to Centre on plea to declare Covishield vaccine as unsafe February 19, 2021 Litigant, who volunteered for trials, claims he suffered side-effects, seeks ₹5-crore compensation The Madras High Court on Friday issued notice to the Centre on a writ petition filed by a litigant to declare Covishield vaccine of Serum Institute of India as unsafe. The litigant, a business consultant who had volunteered for the trials, claimed that he had suffered from side-effects and that he must be compensated with ₹5 crore, or any other amount as decided by the Court. In November 2020, the litigant sent a legal notice to Serum Institute of India asking for the compensation and asked the Centre and ICMR not to give any approval to manufacture and distribute the vaccine.